Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Thomas W. Donner, M.D.

Research

Research interests

Beta cell preservation in Type 1 diabetes
Prevention of diabetes complications

Recent publications 

  • Donner TW, Magder LS, Zarbalian K. Dietary supplementation with D-tagatose in subjects with type 2 diabetes leads to weight loss and raises HDL cholesterol. Nutrition Research 2010;30:801-6. 
  •  Donner T, Munoz M. Update on Insulin Therapy for Type 2 Diabetes. J Clin Endocrinol Metab  2012;97:1405-1413.
  • Hamad A, Arcara K, Uddin S, Donner T. Potentials of Fas ligand (apoptosis-inducing molecule) as an unconventional therapeutic target in type 1 diabetes. Front Immun 2012;3:1-8.
  • Kharlip J, Naglieri R, Mitchell B, Ryan K., Donner T. Screening for Silent Coronary Heart Disease in Type 2 Diabetes: Clinical application of American Diabetes Association guidelines. Diabetes Care 2006;29: 692-694.

  • Havas  S, Donner T. Tight Control of Type 1 Diabetes: Recommendations for Patients. Am Fam Physician 2006;74:971-978.

  • Donner T.  Tight Control of Hyperglycemia in Type 2 Diabetes. Insulin 2006;1:166-172.

  • Donner T, Flammer K. Diabetes Management in the Hospital. Med Clin N Am  2008;92(2):407- 425.

  • Lu Y, Levin G, Donner T. Tagatose, a new antidiabetic and obesity control drug.  Diabetes, Obesity and Metabolism 2008;10;109-134.

  • de Boer IH, Kestenbaum B, Rue TC, Steffes MW, Cleary PA, Molitch ME, Lachin JM,  Weiss NS, Brunzell JD; for the Diabetes Control and Complications Trial  (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group.  Insulin Therapy, Hyperglycemia, and Hypertension in Type 1 Diabetes Mellitus. Arch Intern Med 2008;168(17):1867-1873.

  • Fernandez-Egea E, Bernardo M, Donner T, Conget I, Parellada E, Justicia A, Esmatjes E,  Garcia-Rizo C, Kirkpatrick B. The Metabolic Profile of Antipsychotic-Naive Patients with Nonaffective Psychosis. Brit J Psych 2009;194:434-438.

  •  The BARI 2D Study Group. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. N Engl J Med 2009;360:2503-2515.

  • Shaya FT, Yan X, Lin PJ, Simoni-Wastila L, Bron M, Baran R, Donner TW. US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes. J Clin Hypertens 2010;12(10):826-32. 

  • Donner TW, Magder LS, Zarbalian K. Dietary supplementation with D-tagatose in subjects with type 2 diabetes leads to weight loss and raises HDL cholesterol. Nutrition Research In Press.

 

Traveling for care?

blue suitcase

Whether crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.

U.S. 1-410-464-6713 (toll free)
International +1-410-614-6424

 

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer